To investigate the association of the 2011 American Academy of Otolaryngology Head and Neck Surgery guidelines with perioperative care processes and outcomes in children undergoing tonsillectomy.
Tonsillectomy is one of the most common surgical procedures performed in children. Typical indications include sleep-disordered breathing and recurrent throat infections. 1 More than 500 000 ambulatory tonsillectomies are performed yearly in the United States. 2 Tonsillectomy ranks as the ninth most cumulatively expensive reason for care at children's hospitals. 3 It is generally a safe procedure, and deaths after tonsillectomy occur rarely, about 1 in 30 000 cases. 4 Revisits to hospital for complications occur in 5% to 15%, with the most common reasons related to bleeding, vomiting or dehydration, and pain. [5] [6] [7] In January 2011, the American Academy of Otolaryngology and Head and Neck Surgery (AAOHNS) published guidelines for high-quality tonsillectomy care, including specific recommendations about perioperative care. 1 The guideline recommends perioperative dexamethasone to prevent postoperative nausea and vomiting and the avoidance of perioperative prophylactic antibiotics because they do not prevent infections or bleeding. Both recommendations are based on evidence from randomized controlled trials. 8, 9 In our previous study of children undergoing same-day tonsillectomy at children's hospitals before guideline publication, 69.6% received dexamethasone and 31.3% received antibiotics. 7 The guidelines also make recommendations for hospitals to implement effective pain management strategies, with discharge education to caregivers for pain assessment and management at home. Furthermore, the guidelines suggest that postoperative hemorrhage rates be monitored for quality improvement purposes.
The objective of this study was to investigate the association of the 2011 AAOHNS guidelines with tonsillectomy perioperative care and outcomes in US children's hospitals. Specifically, we were interested in examining whether the evidencebased processes recommended by the guideline, namely administration of dexamethasone and no use of antibiotics, changed after publication of the guidelines. We also examined the outcome of tonsillectomy-related complications, including bleeding, after publication of the guideline.
METHODS
This multicenter retrospective, longitudinal study used data from the Pediatric Health Information System (PHIS). PHIS includes administrative and billing data from 47 freestanding children's hospitals that are located in 26 states and the District of Columbia and affiliated with the Children's Hospital Association. The database contains information on demographics, diagnosis and procedure codes, service locations, and charges. Encrypted medical record numbers permit identification of patients across multiple hospitalizations. Data quality and reliability are maintained by the Children's Hospital Association and participating hospitals. 10 The institutional review board of Cincinnati Children's Hospital deemed this study exempt from review under 45 CFR 46.102(bf) because the participants were not readily identifiable.
Study Population
We included children aged 1 to 18 years undergoing tonsillectomy who were either discharged the same day as surgery or the day after surgery; only patients from the 29 hospitals that provided continuous data into PHIS throughout the entire study period, January 1, 2009 to January 31, 2013, were included. Children were identified using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) procedure codes of tonsillectomy (28.2) or tonsillectomy and adenoidectomy (28.3). We excluded children for the following reasons: diagnosis codes for peritonsillar abscess; children with chronic complex conditions 11 including malignancies, diabetes, bleeding disorders, trisomy 21, and craniofacial disorders 12 who are excluded from the AAOHNS guidelines; a malignancy diagnosis during the index admission or in the year after tonsillectomy; tonsillectomy performed after transfer from another hospital or from the emergency department (ED), because these were considered nonelective; and who had concomitant procedures (eg, esophagogastroduodenoscopy with biopsy, tooth extraction, circumcision, orchiopexy). By creating a cohort that follows the inclusion criteria of the 2011 AAOHNS guidelines and excludes these other groups, we attempted to minimize patient characteristics and circumstances that may warrant deviation from guideline recommendations.
We defined the preguideline period from January 1, 2009 to December 31, 2010 and the postguideline period from January 1, 2011 to January 31, 2013.
Covariates
We analyzed the following covariates: age (1-3, 4-9, 10-18 years), gender, insurance type (government vs nongovernment), race, and a diagnosis code of asthma. 13 We included asthma as a covariate because it is a chronic condition that meets inclusion criteria for the guidelines and has been associated with an elevated complication rate. 14, 15 We also classified the indication for surgery into the following categories: infection related (children who had an infectionrelated code), airway obstruction related (children who had an airway obstruction-related code), both infection related and airway obstruction related, or other (neither an infection or airway obstruction-related code) based on a previous ICD-9-CM classification. 1 
Outcomes

Dexamethasone and Antibiotic Use
We determined whether children were prescribed dexamethasone and antibiotics on the day of surgery based on the presence of pharmacy billing codes.
Revisits to Hospital for Tonsillectomy Related Complications
We evaluated revisits to the same hospital in the first 30 days after surgery. Revisits included visits to the ED and also admissions to the hospital (inpatient unit or observation unit) and ambulatory surgical center. Revisits were classified as tonsillectomy related or unrelated based on our previously defined an ICD-9-CM classification scheme; we included only tonsillectomy-related revisits in our analysis. 7 We also examined specific reasons for revisits: bleeding, vomiting or dehydration, pain, infections, respiratory, and other (including unspecified surgical complications and drug reactions), based on the ICD-9-CM principal diagnosis code on the revisit. 7 Furthermore, we evaluated readmissions due to bleeding and those that necessitated a procedure to control bleeding (ICD-9-CM procedure codes 28.7 control of hemorrhage after tonsillectomy and adenoidectomy and 39.98 control of hemorrhage not otherwise specified).
Analysis
We summarized preguideline and postguideline categorical variables by using frequencies with percentages and compared them by using x 2 tests. We described continuous variables by using median with interquartile range values and compared them by using Wilcoxon rank-sum tests. Segmented regression analysis of interrupted time series was used for modeling monthly rates of the outcomes, clustering on hospital. From these models, we were able to estimate the baseline rate, the preguideline monthly change in the rate, the level change in the rate at the point the guideline was released, and the difference in the monthly change in the rate from preguideline to postguideline. All statistical analysis was performed using SAS version 9.3 (SAS Institute, Inc, Cary, NC), and P ,.05 were considered statistically significant.
RESULTS
There were 111 813 children across 29 hospitals who were included in the study, with 54 043 and 57 770 in the preguideline and postguideline periods, respectively (Fig 1) . The majority of children had a tonsillectomy with adenoidectomy (91.8%), were 4 to 9 years old (58.0%), had an airway obstruction indication diagnosis code (66.3%), and had same-day surgery (77.3%). Table 1 describes the demographic characteristics by guideline period.
Evidence-Based Care Processes
Among patients, there was an increase in the use of dexamethasone from 74.6% to 77.4% (P , .001) and a reduction in the use of antibiotics from 34.7% to 21.8% (P , .001) in the preguideline period compared with the postguideline period (Table 2) . Similarly, among hospitals there was an increase in median dexamethasone use from 84.1% to 89.3% (P = .86) and a reduction in median antibiotic use from 25.9% to 11.1% (P = .02) during the same comparison periods (Table 2 ).
Analysis by interrupted time series provides trends in the rate of change over time from the preguideline period to the postguideline period for dexamethasone and antibiotic use among patients (Fig 2 A and B) . For dexamethasone, the rate of use was 74.2% at the beginning of the preguideline period, and there was a nonsignificant reduction in use of 0.02% per month during the preguideline period (P = .65). After
FIGURE 1
Cohort flow diagram. publication of the guideline, there was a significant increase in the use of dexamethasone to 0.29% per month (P , .001) and 79.3% by the end of the postguideline period. If the preguideline trajectory had been maintained, the projected use at the end of the study period would have been 73.2%.
The rate of antibiotic use was 37.1% at the beginning of the preguideline period, and there was a significant reduction in use of 0.17% per month before guideline publication (P = .007). At the time of guideline publication, antibiotic use dropped by 4.0% (P , .001). After publication of the guidelines, there was a significant reduction in its use of 0.56% per month (P , .001) to 15.1% at the end of the postguideline period. If the preguideline trajectory had been maintained, the projected use at the end of the study period would have been 28.8%.
Tonsillectomy-Related Revisits to Hospital for Complications
Over the entire 48-month study period, 9624 (8.6%) of 111 813 children returned to hospital within 30 days for a tonsillectomy-related complication. Of children who had a revisit, 68.3% (n = 6578) had a revisit to the ED, 31.8% (n = 3065) had a revisit necessitating hospital admission, and 4.9% (n = 470) had a revisit to the ambulatory surgical center. There was an increase in the 30-day revisit rate to hospital from 8.2% to 9.0% (P , .001), attributed to an increase in ED revisits from the preguideline to postguideline period (Table 2) . Similarly, among hospitals there was an increase in the 30-day revisit rate, again caused by an increase in ED revisits from a median hospital rate of 8.0% to 8.8%, although this increase was not statistically significant (P = .22) ( Table 2 ).
The most common reason for a revisit was bleeding, followed by vomiting and dehydration, and there was no difference in their rates over the guideline periods (Table 3 ). However, there was a significant increase in revisits due to pain from the preguideline period to the postguideline period that was evident at both the patient and the hospital level (P , .001) ( Table 3) . Readmissions due to bleeding and those that necessitated a procedure to control bleeding did not change significantly over the guideline periods (Table 4 ).
The analysis of the 30-day revisit rate over time revealed that the increase in revisits predated publication of the guidelines (Fig 2C) . The rate at the beginning of the preguideline period was 8.0% and was increasing at a rate of 0.02% per month during this period (P = .39). After publication of the guidelines, the rate continued to increase by 0.01% per month (P = .77). The 30-day revisit rate at the end of the study period was 9.2%. If the preguideline rate had been maintained, the rate would have been 9.1%.
DISCUSSION
In a multicenter cohort of children undergoing tonsillectomy at children's hospitals, we observed a small increase in dexamethasone use and a substantial reduction in antibiotic use in the first 2 years after publication of the 2011 AAOHNS guidelines. Revisits for tonsillectomy-related complications have increased modestly over time; bleeding rates remained stable, and revisits for pain increased. These findings suggest that perioperative processes of care are more consistent with evidence-based practice, but tonsillectomy complication-related outcomes have not improved. These results were consistent at both the patient and hospital levels.
A recent study evaluated the impact of the 2011 AAOHNS guidelines by surveying 280 US otolaryngologists within a year after guideline publication. 16 Almost half (46%) reported continuing to prescribe perioperative antibiotics, and 90% reported administering perioperative steroids. Our study findings differ because we did not rely on self-report but assessed the use of dexamethasone and antibiotics using administrative billing data in a large cohort of children and up to 2 years after guideline publication. We also examined the rate of change in these process measures to provide a better understanding of temporal changes in practice in relation to guideline publication. Furthermore, we not only evaluated process measures but also evaluated patient outcomes relevant to the tonsillectomy perioperative phase.
Dexamethasone use increased only slightly after guideline publication despite the strong recommendation that all children receive it perioperatively. There are many reasons why physicians may not adhere to clinical practice guideline recommendations. They include a lack of awareness and familiarity with the guideline, lack of agreement with guideline recommendations, lack of selfefficacy, belief that guideline recommendations will not improve outcomes, inability to overcome the inertia of previous practice, and presence of external barriers. 17 Uncertainty about the safety of dexamethasone and disagreement with guideline recommendations may explain the lack of greater adoption, as 1 trial published before our study period reported a greater risk of bleeding with dexamethasone. 18 Subsequent safety evidence published during or after the postguideline period in this study has been conflicting, and thus the use of dexamethasone has been a point of controversy. 19 A noninferiority trial found that there was no increased risk of bleeding associated with dexamethasone; however, this trial has been criticized as having set an inappropriately large noninferiority margin for bleeding that necessitated reoperation (ie, 5%). 20, 21 A meta-analysis and a large observational study concluded that there is no clinically important risk of bleeding associated with dexamethasone use. 22, 23 However, another metaanalysis, which specifically examined the need for reoperation for bleeding, found an increased risk of bleeding necessitating reoperation with dexamethasone use. 24 Antibiotic use was dropping before the publication of the guidelines, and this reduction accelerated after guideline publication. The reduction in antibiotic use over the study period was both clinically and statistically significant and important given that tonsillectomy is such a common surgery. This reduction in unnecessary antibiotic use minimizes the potential for antibiotic adverse events and emergence of antimicrobial resistance, and it contributes to antibiotic stewardship efforts. These data on the change in the process measures over time suggest that the AAOHNS guidelines have had an impact on practice evident even in the first 2 years after publication. However, it is important to note that there are still outlier hospitals with inappropriately high antibiotic use and low dexamethasone use. It will be important to understand the reasons for guideline nonadherence in hospitals to direct quality improvement interventions.
We did not observe a similar impact on tonsillectomy complication-related outcomes, because revisits did not decrease over time. This finding is not surprising because there is a lack of evidence on the most important factors or bundle of care necessary to reduce tonsillectomy-related revisits.
The guidelines do make recommendations on the discharge education of families about posttonsillectomy pain management; however, the implementation of these recommendations or patient compliance may have been suboptimal. One would not expect a reduction in antibiotic use to have a significant impact on revisits.
Although dexamethasone is effective in reducing postoperative nausea and vomiting, it has not been shown to reduce hospital revisits. 7 Reducing revisits for tonsillectomy-related complications probably requires reliable implementation of a host of factors such as the optimal surgical technique, pain management, followup support for families, and revisit prevention strategies.
A concerning observation from our study was the increase in revisits due to pain at both the patient and hospital levels. During the study period, codeine-related deaths and respiratory depression in children after tonsillectomy were reported. 25, 26 The Food and Drug Administration then required that manufacturers of all codeinecontaining products add a boxed warning of this risk related to codeine after tonsillectomy (and adenoidectomy) in children and a contraindication to its use in this population. 27 The AAOHNS also endorsed these requirements. 27 With this practice shift in pain management, it is possible that a lack of comfort with alternatives, such as ibuprofen or selective use of morphine, resulted in undertreatment of pain and an
FIGURE 2
Actual, modeled, and projected trajectories of (A) dexamethasone use, (B) antibiotic use, and (C) 30-day tonsillectomy-related revisits across 29 children' s hospitals, January 2009 to January 2013.
increase in revisits. Our observation of increased revisits due to pain warrants additional exploration to understand the actual practice of tonsillectomy pain medication prescription and management as an area for improvement.
There are several limitations to this study. We evaluated the impact of only the guideline recommendations with respect to perioperative care and not other recommendations, such as when to perform a tonsillectomy. Our data source did not allow us to track revisits across hospitals, which may have led us to underestimate the rate of tonsillectomy-related complications. Our findings represent the practice and outcomes at large children's hospitals and may not be generalizable to other surgical practice settings. Although results were consistent at the patient and hospital level, some comparisons were not statistically significant at the hospital level, probably because we were underpowered for comparisons at the hospital level because of the small number of hospitals. We did not have data on postdischarge antibiotic prescribing, a practice that is not supported by randomized controlled trials but is common among some surgeons. 9 We did not have data on hospitals' guideline implementation strategies, which may have explained the variation across hospitals. We were also not able to examine the role of other variables important to understanding tonsillectomy-related complications, such as surgical technique and specific discharge management practices such as pain medication prescriptions and outpatient follow-up.
CONCLUSIONS
The 2011 AAOHN tonsillectomy guideline was associated with some improvement in tonsillectomy evidence-based processes of care but no improvement in complicationrelated outcomes in the first 2 years after publication. There was a small increase in perioperative dexamethasone use and a substantial reduction in perioperative antibiotic use. Revisits to hospital for tonsillectomy complications increased due to revisits for pain.
Additional research and quality improvement efforts are needed to reduce complication-related revisits and, in particular, revisits due to pain. 
